Position in SCLX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$264,122
New position
Shares Held
39,658
first reported quarter
Ownership
0.467%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026VANGUARD FIDUCIARY TRUST CO holds $17,890,035,810 across 13 Drug Manufacturers - General names. SCLX ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,619,489 | $4,248,867,397 | |
| 2 | JNJ |
Johnson & Johnson
|
13,564,489 | $3,315,703,691 | |
| 3 | AZN |
Astrazeneca PLC
|
13,195,178 | $2,602,353,005 | |
| 4 | ABBV |
AbbVie Inc.
|
10,199,396 | $2,218,266,636 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,964,179 | $1,679,751,091 | |
| 6 | AMGN |
Amgen Inc
|
3,087,634 | $1,086,384,022 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,032,718 | $980,149,907 | |
| 8 | PFE |
Pfizer Inc
|
32,001,259 | $898,595,352 |
All Filings in SCLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $264,122 | 39,658 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||